EUVIMEDEUVIMED entdecken
Crossref

Synthesis of new 2-styryl-3-nitroimidazo[1,2-a]pyridine derivatives via base-induced elimination of 2-N-tosyl intermediates and in vitro antileishmanial evaluation

Inès Jacquet, Caroline Castera-Ducros, Romain Paoli-Lombardo, Isma Saadi, Sandra Bourgeade-Delmas, Nicolas Primas, Patrice Vanelle

Bioorganic & Medicinal Chemistry · 2026-08 · 139 · 118683

DOI: 10.1016/j.bmc.2026.118683 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry, 2026-08. Verfasst von Inès Jacquet und 6 weiteren Autor:innen. Beteiligte Einrichtung: Aix Marseille Univ, CNRS, ICR UMR 7273, Team Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, 13385 Marseille, France. Electronic address: ines.jac…. Hauptthemen laut MEDLINE: Antiprotozoal Agents, Pyridines, Leishmania. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To explore the antileishmanial structure-activity relationships in a 3-nitroimidazo[1,2-a]pyridine series, we developed a previously undescribed olefination strategy at position 2 via elimination of intermediates bearing an N-tosyl group, giving access to E-configured alkenes. Subsequent modulation at position 8 was performed through nucleophilic aromatic substitutions and Suzuki-Miyaura cross-coupling reactions. This work resulted in 21 original compounds, whose antileishmanial activity, cytotoxicity, and nitro group reduction potential were evaluated. These results provide a new synthetic access to unexplored 2-substituted derivatives and deepen our understanding of the reactivity at position 2 in relation to biological activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiprotozoal AgentsPyridinesLeishmaniaStructure-Activity RelationshipAnimalsParasitic Sensitivity TestsMolecular StructureDose-Response Relationship, Drug

Stichwörter der Autor:innen

3-Nitroimidazo[1,2-a]pyridinesEliminationLeishmaniaNitroaromatic compoundsNucleophilic aromatic substitutionOlefinationPalladium-catalyzed cross-coupling

Substanzen

Antiprotozoal AgentsPyridines

Autor:innen und Institutionen

  • Aix Marseille Univ, CNRS, ICR UMR 7273, Team Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, 13385 Marseille, France. Electronic address: ines.jacquet@etu.univ-amu.fr.
  • Aix Marseille Univ, CNRS, ICR UMR 7273, Team Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, 13385 Marseille, France; Service Central de la Qualité et de l'Information Pharmaceutiques, Hôpital de la Conception, AP-HM…
  • Aix Marseille Univ, CNRS, ICR UMR 7273, Team Pharmaco-Chimie Radicalaire, Faculté de Pharmacie, 13385 Marseille, France. Electronic address: isma.saadi@etu.univ-amu.fr.
  • UMR 152 PHARMA-Dev, IRD, UPS, Université de Toulouse, 31062 Toulouse, France. Electronic address: sandra.bourgeade-delmas@ird.fr.

Zitieren

APA

Jacquet, I., Castera-Ducros, C., Paoli-Lombardo, R., Saadi, I., Bourgeade-Delmas, S., Primas, N., & Vanelle, P. (2026). Synthesis of new 2-styryl-3-nitroimidazo[1,2-a]pyridine derivatives via base-induced elimination of 2-N-tosyl intermediates and in vitro antileishmanial evaluation. Bioorganic & Medicinal Chemistry, 139, 118683. https://doi.org/10.1016/j.bmc.2026.118683

Vancouver

Jacquet I, Castera-Ducros C, Paoli-Lombardo R, Saadi I, Bourgeade-Delmas S, Primas N, et al. Synthesis of new 2-styryl-3-nitroimidazo[1,2-a]pyridine derivatives via base-induced elimination of 2-N-tosyl intermediates and in vitro antileishmanial evaluation. Bioorganic & Medicinal Chemistry. 2026;139:118683. doi:10.1016/j.bmc.2026.118683

BibTeX
@article{Jacquet2026,
  author = {Jacquet, Inès and Castera-Ducros, Caroline and Paoli-Lombardo, Romain and Saadi, Isma and Bourgeade-Delmas, Sandra and Primas, Nicolas and Vanelle, Patrice},
  title = {Synthesis of new 2-styryl-3-nitroimidazo[1,2-a]pyridine derivatives via base-induced elimination of 2-N-tosyl intermediates and in vitro antileishmanial evaluation},
  journal = {Bioorganic & Medicinal Chemistry},
  year = {2026},
  volume = {139},
  pages = {118683},
  doi = {10.1016/j.bmc.2026.118683}
}
Kostenlos starten →